法国IMPLANET公司与中国TINAVI合作,在全球分发脊椎手术机器人。 French firm IMPLANET partners with China’s TINAVI to distribute spine surgery robot globally.

法国医疗技术公司IMPLANET与设在北京的TINAVI医疗技术公司签订了独家全球分销协议,将TiRobot脊椎外科系统商业化。 IMPLANET, a French medical technology company, has entered an exclusive global distribution agreement with Beijing-based TINAVI Medical Technologies to commercialize the TiRobot® spine surgery system. 由外科医生为外科医生设计的科毒平台在所有脊椎区域提供实时适应能力,旨在提高精确度、缩短程序时间和加强病人安全。 The cobotic platform, designed by surgeons for surgeons, offers real-time adaptability across all spinal regions and aims to improve precision, reduce procedure time, and enhance patient safety. 该伙伴关系扩大了IMPLANET的先进整形解决方案组合,并支持美国、欧洲和新兴市场的增长。 The partnership expands IMPLANET’s portfolio of advanced orthopedic solutions and supports its growth in the U.S., Europe, and emerging markets. IMPLANET生产脊椎植入物,包括经林业发展局许可的JA系统,据2024年报告,其收入为940万欧元,并通过波士顿的一个美国子公司经营。 IMPLANET, which manufactures spinal implants including its FDA-cleared JAZZ® system, reported €9.4 million in revenue in 2024 and operates through a U.S. subsidiary in Boston. 该公司在巴黎的欧元交易所上市. The company is listed on Euronext Growth in Paris.